These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 35899030)

  • 1. The Effects of Asprosin on Exercise-Intervention in Metabolic Diseases.
    Liu L; Liu Y; Huang M; Zhang M; Zhu C; Chen X; Bennett S; Xu J; Zou J
    Front Physiol; 2022; 13():907358. PubMed ID: 35899030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asprosin, a C-Terminal Cleavage Product of Fibrillin 1 Encoded by the
    Ovali MA; Bozgeyik I
    Mol Syndromol; 2022 May; 13(3):175-183. PubMed ID: 35707591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrillin-1 and asprosin, novel players in metabolic syndrome.
    Summers KM; Bush SJ; Davis MR; Hume DA; Keshvari S; West JA
    Mol Genet Metab; 2023 Jan; 138(1):106979. PubMed ID: 36630758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular cloning, characterization and 3D modelling of spotted snakehead fbn1 C-terminal region encoding asprosin and expression analysis of fbn1.
    Sathoria P; Chuphal B; Rai U; Roy B
    Sci Rep; 2023 Mar; 13(1):4470. PubMed ID: 36934166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asprosin-A Fasting-Induced, Glucogenic, and Orexigenic Adipokine as a New Promising Player. Will It Be a New Factor in the Treatment of Obesity, Diabetes, or Infertility? A Review of the Literature.
    Mazur-Bialy AI
    Nutrients; 2021 Feb; 13(2):. PubMed ID: 33673009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrillin-1 and fibrillin-1-derived asprosin in adipose tissue function and metabolic disorders.
    Muthu ML; Reinhardt DP
    J Cell Commun Signal; 2020 Jun; 14(2):159-173. PubMed ID: 32279186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asprosin, a novel glucogenic adipokine implicated in type 2 diabetes mellitus.
    Diao H; Li X; Xu Y; Xing X; Pang S
    J Diabetes Complications; 2023 Nov; 37(11):108614. PubMed ID: 37769508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asprosin, a novel pleiotropic adipokine implicated in fasting and obesity-related cardio-metabolic disease: Comprehensive review of preclinical and clinical evidence.
    Shabir K; Brown JE; Afzal I; Gharanei S; Weickert MO; Barber TM; Kyrou I; Randeva HS
    Cytokine Growth Factor Rev; 2021 Aug; 60():120-132. PubMed ID: 34108103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asprosin: A Novel Player in Metabolic Diseases.
    Yuan M; Li W; Zhu Y; Yu B; Wu J
    Front Endocrinol (Lausanne); 2020; 11():64. PubMed ID: 32153505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Energy Regulation Mechanism and Therapeutic Potential of Asprosin.
    Hoffmann JG; Xie W; Chopra AR
    Diabetes; 2020 Apr; 69(4):559-566. PubMed ID: 32198197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asprosin in health and disease, a new glucose sensor with central and peripheral metabolic effects.
    Farrag M; Ait Eldjoudi D; González-Rodríguez M; Cordero-Barreal A; Ruiz-Fernández C; Capuozzo M; González-Gay MA; Mera A; Lago F; Soffar A; Essawy A; Pino J; Farrag Y; Gualillo O
    Front Endocrinol (Lausanne); 2022; 13():1101091. PubMed ID: 36686442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OLFR734 Mediates Glucose Metabolism as a Receptor of Asprosin.
    Li E; Shan H; Chen L; Long A; Zhang Y; Liu Y; Jia L; Wei F; Han J; Li T; Liu X; Deng H; Wang Y
    Cell Metab; 2019 Aug; 30(2):319-328.e8. PubMed ID: 31230984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asprosin and type 2 diabetes mellitus: a novel potential therapeutic implication.
    Bhadel P; Shrestha S; Sapkota B; Li JY; Tao H
    J Biol Regul Homeost Agents; 2020 Feb; 34(1):. PubMed ID: 32080995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asprosin, a Fasting-Induced Glucogenic Protein Hormone.
    Romere C; Duerrschmid C; Bournat J; Constable P; Jain M; Xia F; Saha PK; Del Solar M; Zhu B; York B; Sarkar P; Rendon DA; Gaber MW; LeMaire SA; Coselli JS; Milewicz DM; Sutton VR; Butte NF; Moore DD; Chopra AR
    Cell; 2016 Apr; 165(3):566-79. PubMed ID: 27087445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of a possible role of asprosin in ovarian follicular function.
    Maylem ERS; Spicer LJ; Batalha I; Schutz LF
    J Mol Endocrinol; 2021 Jan; 66(1):35-44. PubMed ID: 33112803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A potential role of fibrillin-1 (FBN1) mRNA and asprosin in follicular development in water buffalo.
    Maylem ERS; Spicer LJ; Atabay EP; Atabay EC; Batalha I; Schutz LF
    Theriogenology; 2022 Jan; 178():67-72. PubMed ID: 34781067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel adipokine asprosin modulates browning and adipogenesis in white adipose tissue.
    Miao Y; Qin H; Zhong Y; Huang K; Rao C
    J Endocrinol; 2021 May; 249(2):83-93. PubMed ID: 33705351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein tyrosine phosphatase receptor δ serves as the orexigenic asprosin receptor.
    Mishra I; Xie WR; Bournat JC; He Y; Wang C; Silva ES; Liu H; Ku Z; Chen Y; Erokwu BO; Jia P; Zhao Z; An Z; Flask CA; He Y; Xu Y; Chopra AR
    Cell Metab; 2022 Apr; 34(4):549-563.e8. PubMed ID: 35298903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can the new adipokine asprosin be a metabolic troublemaker for cardiovascular diseases? A state-of-the-art review.
    Zhang Z; Zhu L; Wang Z; Hua N; Hu S; Chen Y
    Prog Lipid Res; 2023 Jul; 91():101240. PubMed ID: 37473965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and purification of asprosin in Pichia pastoris and investigation of its increase glucose uptake activity in skeletal muscle through activation of AMPK.
    Zhang Y; Zhu Z; Zhai W; Bi Y; Yin Y; Zhang W
    Enzyme Microb Technol; 2021 Mar; 144():109737. PubMed ID: 33541572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.